Name | SHR-1701 |
---|
Description | SHR-1701 (Retlirafusp alfa) is a bifunctional fusion protein targeting PD-L1 and TGF-β for cancer research[1]. |
---|---|
Related Catalog | |
In Vitro | SHR-1701 (10 μg/mL)可以抑制 TGF-β 信号通路,激活 PI3K/Akt/Erk 信号通路,挽救淋巴细胞恢复受损的肺癌患者外周血CD8+ T 细胞的抗肿瘤功能[1]。 |
References |
No Any Chemical & Physical Properties |